← Today’s ReceiptsSource pending
Public-record receiptR-WISource pending
Tony Wied disclosed BUY $HIMS
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$500K – $1.0M
Filed
2026-03-09
Trade date
2026-02-03
Disclosure lag
34 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 34 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $500K – $1.0M, which is the public reporting band rather than an exact profit or loss figure.
41 nearby same-ticker disclosure appeared in the surrounding 30-day window.
5Committee context is available for Tony Wied, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 9 lobbying filings.
Source
source pending
Source: indexed congressional disclosure; official source link pending · filed 2026-03-09 · disclosed 34d after transaction
Market context
HIMS
Vs SPY: 26.0%
Factual flags
- 9 lobbying filings linked to this ticker.
- 1 nearby same-ticker disclosure in the surrounding 30-day window.
- Disclosed range upper bound: $1,000,000.
- HIMS transaction date was 11d after a public lobbying filing by HIMS & HERS HEALTH INC. ($330,000); this is timing context, not a finding of intent.
Member trail
Tony Wied
U.S. House · WI-8
House Committee on Transportation and InfrastructureHouse Committee on AgricultureHouse Committee on Small Business
Ticker trail
$HIMS
Company metadata pending
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.